| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 01/15/1997 | EP0752874A1 Enhanced virus-mediated dna transfer |
| 01/15/1997 | EP0752861A1 Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors |
| 01/15/1997 | CN1033808C Process for preparing steroids substd. omega-phenylamino alkanoic acids and their salts |
| 01/14/1997 | US5593981 Method and treatment of androgen-related diseases |
| 01/08/1997 | CN1033753C Process for the preparation of 11 beta-phenyl-gonanes |
| 01/07/1997 | US5591734 17-(3-furyl)-5β, 14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 01/07/1997 | US5591733 Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/02/1997 | EP0750501A1 Combined hormonal contraception pharmaceutical preparation |
| 12/24/1996 | US5587496 15,15-dialkyl-substituted derivatives of estradiol |
| 12/19/1996 | WO1996040152A1 Dehydroepiandrosterone derivatives for preventing progressive tissue necrosis reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 12/19/1996 | WO1996040043A2 Neuroactive steroids of the androstane and pregnane series |
| 12/19/1996 | CA2223996A1 Neuroactive steroids of the androstane and pregnane series |
| 12/19/1996 | CA2223739A1 Dehydroepiandrosterone derivatives for preventing progressive tissue necrosis reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 12/17/1996 | US5585405 Administering androgen or estrogen inhibitors |
| 12/11/1996 | EP0746322A1 Treatment of alzheimer's disease and modulation of immune system with delta5-androstenes |
| 12/10/1996 | US5583126 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 12/04/1996 | CN1137237A Method of treating androgenic alopecia with 5-alpha reductase inhibitors |
| 12/03/1996 | US5581002 Blocking with butyldimethylsilanyl chloride; alkylation; ozonolyzing with sodium hypochlorite; deblocking |
| 11/27/1996 | EP0744176A2 Methods for inhibiting bone loss |
| 11/26/1996 | US5578726 Process for producing 7 β-substituted-4-aza-5 α-androstan-3-ones |
| 11/26/1996 | US5578718 Thiol-derivatized nucleosides |
| 11/26/1996 | US5578589 Method for suppressing an immunoresponse with an estradiol derivative-chlorambucil conjugate |
| 11/26/1996 | US5578588 Nasal administration of a precursor |
| 11/24/1996 | CA2177115A1 Methods for inhibiting bone loss |
| 11/19/1996 | US5576309 Estradiol derivative-chlorambucil conjugate, process for preparing the same, and pharmaceutical composition |
| 11/14/1996 | WO1996035415A2 Use of sesquiterpenes for inhibiting oxidative enzymes |
| 11/07/1996 | WO1996034858A1 Nicotinic acid esters and pharmaceutical compositions containing them |
| 11/07/1996 | WO1996034855A1 Fatty acid esters as bioactive compounds |
| 11/07/1996 | WO1996034846A1 1,3-propane diol derivatives as bioactive compounds |
| 11/06/1996 | EP0740708A1 Design of drugs involving receptor-ligand-dna interactions |
| 11/06/1996 | EP0740650A1 Codrugs as a method of controlled drug delivery |
| 10/31/1996 | DE19516325A1 High yield prodn. of new or known 14(15)-unsatd. 17alpha-substd. steroid cpds. |
| 10/29/1996 | US5569652 For treatment of menopause disorders; oral contraceptives |
| 10/23/1996 | EP0738275A1 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 10/23/1996 | EP0738157A1 Contrast media for x-ray and magnetic resonance imaging |
| 10/22/1996 | US5567830 Process for synthesis of acetylenic carbinols |
| 10/22/1996 | US5567697 17-(4-pyridazinyl) -5β, 14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 10/22/1996 | US5567694 17-Aryl and 17-heterocyclyl-5β,14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 10/22/1996 | CA1338667C Anti-androgen compounds |
| 10/16/1996 | CN1133296A 11 beta-aromatic group-4-estraene and acid additive salt application in medicine |
| 10/15/1996 | US5565588 Introducing substituents on starting compound containing 9-alpha-hydroxy group |
| 10/09/1996 | EP0735992A1 Method of converting hydroxyl groups into corresponding fluoro compounds |
| 10/09/1996 | CN1133011A Preparation for substitution therapy containing at least one progestogen and at least one extrogen |
| 10/02/1996 | EP0538348B1 UNSATURATED 15-DEHYDRO-17alpha-CYANOMETHYL-17beta- HYDROXYSTEROIDS |
| 10/01/1996 | US5561125 Antitumor agents |
| 09/24/1996 | US5559210 Reagents and methods for the detection and quantification of testosterone in fluid samples |
| 09/19/1996 | WO1996028175A1 Immunomodulating compositions from bile for the treatment of immune system disorders |
| 09/18/1996 | CN1131158A Steroids with 17-spiromethylene lactone or lactol group |
| 09/17/1996 | US5556965 Chemical intermediates for steroids |
| 09/17/1996 | US5556846 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene derivatives active on the cardiovascular system, and pharmaceutical compositions containing same |
| 09/17/1996 | US5556845 11-β substituted-19-nor steroids |
| 09/11/1996 | EP0730458A1 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 09/10/1996 | US5554601 Administering an estrogen compound in the absence of testosterone; treatment of alzheimer*s |
| 09/03/1996 | US5552395 Bone disorders |
| 08/29/1996 | WO1996026201A1 Benzopyran-containing compounds and method for their use |
| 08/29/1996 | WO1996025935A1 Method of treating adenosine depletion |
| 08/28/1996 | EP0728140A1 New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances |
| 08/28/1996 | EP0728004A1 Use of steroids with a phenolic a-ring structure for prophylaxis and therapy of radical-mediated cell damage |
| 08/27/1996 | US5550107 Anticarcinogenic agents and antiestrogens |
| 08/13/1996 | US5545635 Inhibiting bone loss with equilenin |
| 08/08/1996 | WO1996023503A1 Progesterone antagonists useful for preparing medicaments for treating dysfunctional uterine bleeding |
| 08/07/1996 | EP0725074A2 Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives |
| 07/31/1996 | EP0723775A1 Use of dehydroepi-androsterone in cosmetic or dermatologic composition |
| 07/31/1996 | CN1128031A 15,15-dialkyl-substituted derivatives of estradiol |
| 07/16/1996 | US5536714 Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses |
| 07/02/1996 | US5532230 Administering dehydroepiandrosterone or derivatives as antiischemic agent |
| 06/27/1996 | WO1996019212A1 Use of boswellic acid for treating brain tumours |
| 06/27/1996 | WO1996019196A1 INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS |
| 06/27/1996 | DE4445728A1 Verwendung von Boswelliasäure zur Behandlung von Hirntumoren Use of boswellic acid for the treatment of brain tumors |
| 06/26/1996 | EP0717626A1 Preparation for substitution therapy, containing at least one progestogen and at least one extrogen |
| 06/25/1996 | US5529993 Urogenital disorders; contraceptives |
| 06/25/1996 | US5529992 Method for inhibiting myocardial fibrosis by administering an aldosterone antagonist which suppresses aldoster one receptors |
| 06/20/1996 | WO1996013268A3 Use of a corticosteroid to reduce the adverse effects of a perfluorochemical emulsion |
| 06/19/1996 | EP0716604A1 Thiol-derivatized nucleosides and oligonucleosides |
| 06/19/1996 | EP0716599A1 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-$g(b)-ESTRADIOL AND PROCESS FOR ITS PRODUCTION |
| 06/12/1996 | EP0715518A1 Agent for transdermal application containing gestoden esters |
| 06/12/1996 | EP0715517A1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 06/04/1996 | US5523428 Catalytic alkylation in presence of nickel salt and organometallic compound |
| 05/29/1996 | EP0713880A2 Stereoselective reduction of 17-ketosteroids |
| 05/29/1996 | EP0713393A1 Estrogenic compounds as anti-mitotic agents |
| 05/28/1996 | US5521167 Cyclopentanperhydrophenanthren-17β-(hydroxy or alkoxy)-17α-(Aryl or heterocyclyl)-3β-derivatives active on the cardiovascular system, and pharmaceutical compositions containing same |
| 05/22/1996 | EP0712497A1 Reagents and methods for the detection and quantification of testosterone in fluid samples |
| 05/22/1996 | EP0712412A1 15,15-dialkyl-substituted derivatives of estradiol |
| 05/22/1996 | EP0589034A4 Method for making 3-g(a)-hydroxy,3-g(b)-substituted-pregnanes |
| 05/21/1996 | US5519027 D-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 05/15/1996 | EP0711169A1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 05/15/1996 | DE4441596A1 Prepn. of 1 alpha-methyl-3-keto-delta4-steroid derivs. by reacting 3-keto-delta1,4-steroid |
| 05/15/1996 | CN1122226A Tablet, capsule, or granule comprising desogestrel |
| 05/14/1996 | US5516922 Process for the preparation of 10(2-propynyl)estr-4-ene-3,17-dione |
| 05/14/1996 | US5516779 Treatment of skin disorders |
| 05/14/1996 | US5516769 Administering an antiprogestin to prevent ovulation or interfere with the menstrual cycle of a mammal |
| 05/09/1996 | WO1996013474A1 Method of converting hydroxyl groups into corresponding fluoro compounds |
| 05/09/1996 | WO1996013268A2 Use of a corticosteroid to reduce the adverse effects of a perfluorochemical emulsion |
| 05/01/1996 | EP0709394A2 Steroids with a 17-spiromethylene lactone or lactol group |
| 04/28/1996 | CA2161490A1 Steroids with a 17-spiromethylene lactone or lactol group |
| 04/23/1996 | US5510538 Process for the oxidation of primary and secondary alcohols to aldehydes and ketones and for the oxidation of 1,2-diols to α-ketols and α-diketones |
| 04/17/1996 | CN1120834A Ozonide reducing agent |
| 04/09/1996 | US5506223 Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process |
| 04/04/1996 | WO1996010032A1 Novel estrenes for inducing hypothalamic effects |
| 04/04/1996 | WO1996010031A1 Novel androstanes for inducing hypothalamic effects |